OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster
Julien Favresse, Constant Gillot, Julien Cabo, et al.
International Journal of Infectious Diseases (2024) Vol. 143, pp. 107028-107028
Open Access | Times Cited: 14
Julien Favresse, Constant Gillot, Julien Cabo, et al.
International Journal of Infectious Diseases (2024) Vol. 143, pp. 107028-107028
Open Access | Times Cited: 14
Showing 14 citing articles:
Risks of Severe Acute Respiratory Syndrome Coronavirus 2 JN.1 Infection and Coronavirus Disease 2019–Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study
Cheryl Chong, Liang En Wee, Xuan Jin, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 5, pp. 1190-1196
Closed Access | Times Cited: 4
Cheryl Chong, Liang En Wee, Xuan Jin, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 5, pp. 1190-1196
Closed Access | Times Cited: 4
From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 3
Anoop Kumar, Prajna Tripathi, Prashant Kumar, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 459-459
Open Access | Times Cited: 3
Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update
Constant Gillot, Clara David, Jean-Michel Dogné, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Open Access | Times Cited: 1
Constant Gillot, Clara David, Jean-Michel Dogné, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024)
Open Access | Times Cited: 1
Long-Term Immunity Against SARS-CoV-2 Wild Type and Omicron XBB 1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later
Rocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
SARS-CoV-2 Omicron BA.2.86 & JN.1 shifting tropism from airway to intestine
Mcw Chan, Kenrie P. Y. Hui, John Ho, et al.
Research Square (Research Square) (2024)
Open Access
Mcw Chan, Kenrie P. Y. Hui, John Ho, et al.
Research Square (Research Square) (2024)
Open Access
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Lineage-specific neutralising antibodies after SARS-CoV-2 mild disease. Immune boosting effect of vaccination
Carlos Daviña Núñez, Sonia Pérez‐Castro, Jorge Julio Cabrera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Carlos Daviña Núñez, Sonia Pérez‐Castro, Jorge Julio Cabrera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Humoral Immunity and Clinical Characteristics of Chinese College Students Experiencing a BA.5/BF.7 and XBB.1.5 wave
Yuchen Xie, Ying Chen, Yuzhu Shi, et al.
Research Square (Research Square) (2024)
Open Access
Yuchen Xie, Ying Chen, Yuzhu Shi, et al.
Research Square (Research Square) (2024)
Open Access
SARS-CoV-2 Omicron XBB infections boost cross-variant neutralizing antibodies, potentially explaining the observed delay of the JN.1 wave in some Brazilian regions
Luis Fernando López Tort, Mia Ferreira de Araújo, Ighor Arantes, et al.
IJID Regions (2024) Vol. 14, pp. 100503-100503
Open Access
Luis Fernando López Tort, Mia Ferreira de Araújo, Ighor Arantes, et al.
IJID Regions (2024) Vol. 14, pp. 100503-100503
Open Access
Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates
Dongrong Yi, Yongxin Zhang, Jing Wang, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access
Dongrong Yi, Yongxin Zhang, Jing Wang, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access
Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 Omicron subvariant during pregnancy - A case series study
Marie Didembourg, Clara David, Laure Morimont, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41249-e41249
Open Access
Marie Didembourg, Clara David, Laure Morimont, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41249-e41249
Open Access
Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
P. von der Schulenburg, Georg M. N. Behrens, Markus Hoffmann, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1942-1942
Open Access
P. von der Schulenburg, Georg M. N. Behrens, Markus Hoffmann, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1942-1942
Open Access
Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later
Rocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
Journal of Infection (2024), pp. 106402-106402
Open Access
Rocío Rubio, Alexei Yavlinsky, Marina Escalera Zamudio, et al.
Journal of Infection (2024), pp. 106402-106402
Open Access
